ESOMEPRAZOLE MAGNESIUM capsule, delayed release

Land: USA

Språk: engelsk

Kilde: NLM (National Library of Medicine)

Kjøp det nå

Preparatomtale Preparatomtale (SPC)
17-08-2022

Aktiv ingrediens:

ESOMEPRAZOLE MAGNESIUM (UNII: R6DXU4WAY9) (ESOMEPRAZOLE - UNII:N3PA6559FT)

Tilgjengelig fra:

Lake Erie Medical DBA Quality Care Products LLC

INN (International Name):

ESOMEPRAZOLE MAGNESIUM

Sammensetning:

ESOMEPRAZOLE 40

Administreringsrute:

ORAL

Resept typen:

PRESCRIPTION DRUG

Indikasjoner:

Healing of Erosive Esophagitis Esomeprazole magnesium delayed-release capsules, USP are indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis. For those patients who have not healed after 4 to 8 weeks of treatment, an additional 4 to 8 week course of esomeprazole magnesium delayed-release capsules, USP may be considered. Maintenance of Healing of Erosive Esophagitis Esomeprazole magnesium delayed-release capsules, USP are indicated to maintain symptom resolution and healing of erosive esophagitis. Controlled studies do not extend beyond 6 months. Symptomatic Gastroesophageal Reflux Disease Esomeprazole magnesium delayed-release capsules, USP are indicated for short-term treatment (4 to 8 weeks) of heartburn and other symptoms associated with GERD in adults. Esomeprazole magnesium delayed-release capsules, USP are indicated for the reduction in the occurrence of gastric ulcers associated with continuous NSAID therapy in p

Produkt oppsummering:

Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, are size '4' hard gelatin capsule having yellow cap and pink body imprinted as '20 mg' on the body with white ink and '1154' on the cap with black ink, containing off white to cream colored granules. They are supplied as follows: Esomeprazole Magnesium Delayed-Release Capsules, USP 40 mg, are size '2' hard gelatin capsule having pink cap and body, imprinted as '40 mg' on the body and '1155' on the cap with white ink, containing off white to cream colored granules. They are supplied as follows: 55700-428-30 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Keep Esomeprazole Magnesium Delayed-Release Capsules, USP container tightly closed. Dispense in a tight container with a child-resistant closure.

Autorisasjon status:

Abbreviated New Drug Application

Informasjon til brukeren

                                ESOMEPRAZOLE MAGNESIUM- ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED
RELEASE
Lake Erie Medical DBA Quality Care Products LLC
----------
MEDICATION GUIDE
Esomeprazole Magnesium (ee so MEP ra zol mag NEE zee um)
Delayed-Release Capsules, USP
Read the Medication Guide that comes with esomeprazole magnesium
delayed-release capsules before you
start taking esomeprazole magnesium delayed-release capsules and each
time you get a refill. There may be
new information. This information does not take the place of talking
with your doctor about your medical
condition or your treatment.
What is the most important information I should know about
esomeprazole magnesium delayed-release
capsules?
Esomeprazole magnesium delayed-release capsules may help your
acid-related symptoms, but you could still
have serious stomach problems. Talk with your doctor.
Esomeprazole magnesium delayed-release capsules can cause serious side
effects, including:
•
Diarrhea . Esomeprazole magnesium delayed-release capsules may
increase your risk of getting
severe diarrhea. This diarrhea may be caused by an
infection(Clostridium difficile) in your intestines.
Call your doctor right away if you have watery stool, stomach pain,
and fever that does not go away.
•
Bone fractures . People who take multiple daily doses of Proton Pump
Inhibitor medicines for a long
period of time (a year or longer) may have an increased risk of
fractures of the hip, wrist, or spine.
You should take esomeprazole magnesium delayed-release capsules
exactly as prescribed, at the
lowest dose possible for your treatment and for the shortest time
needed. Talk to your doctor about
your risk of bone fracture if you take esomeprazole magnesium
delayed-release capsules.
Esomeprazole magnesium delayed-release capsules can have other serious
side effects. See "What are the
possible side effects of esomeprazole magnesium delayed-release
capsules?"
What are esomeprazole magnesiumdelayed-release capsules?
Esomeprazole magnesium delayed-release capsules are a prescription
medicine called a pro
                                
                                read_full_document
                                
                            

Preparatomtale

                                ESOMEPRAZOLE MAGNESIUM- ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED
RELEASE
LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
ESOMEPRAZOLE
MAGNESIUM DELAYED-RELEASE CAPSULES SAFELY AND EFFECTIVELY. SEE FULL
PRESCRIBING
INFORMATION FOR ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES.
ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES USP, FOR ORAL USE
INITIAL U.S. APPROVAL: 1989 (OMEPRAZOLE)
RECENT MAJOR CHANGES
Warnings and Precautions, Interactions with Diagnostic
Investigations for Neuroendocrine Tumors (5.10) 03/2014
Contraindications (4) 12/2014
Warnings and Precautions, Acute Interstitial Nephritis (5.3) 12/2014
Warnings and Precautions, Cyanocobalamin (vitamin B-12)
Deficiency (5.4) 12/2014
INDICATIONS AND USAGE
Esomeprazole magnesium is a proton pump inhibitor indicated for the
following: (1)
Treatment of gastroesophageal reflux disease (GERD) (1.1)
Risk reduction of NSAID-associated gastric ulcer (1.2)
_H. pylori_ eradication to reduce the risk of duodenal ulcer
recurrence (1.3)
Pathological hypersecretory conditions, including Zollinger-Ellison
syndrome (1.4)
DOSAGE AND ADMINISTRATION
Indication
Dose
Frequency
GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Adults
20 mg or 40 mg Once daily for 4 to 8 weeks
12 to 17 years
20 mg or 40 mg Once daily for up to 8 weeks
1 to 11 years
10 mg or 20 mg Once daily for up to 8 weeks
RISK REDUCTION OF NSAID-ASSOCIATED GASTRIC ULCER
20 mg or 40 mg Once daily for up to 6 months
_H. PYLORI _ERADICATION _(Triple Therapy_):
Esomeprazole Magnesium
40 mg
Once daily for 10 days
Amoxicillin
1000 mg
Twice daily for 10 days
Clarithromycin
500 mg
Twice daily for 10 Days
PATHOLOGICAL HYPERSECRETORY CONDITIONS
40 mg
Twice daily
See full prescribing information for administration options (2) (2)
Patients with severe liver impairment-do not exceed dose of 20 mg (2)
(2)
DOSAGE FORMS AND STRENGTHS
Esomeprazole Magnesium Delayed-Release Capsules: 20 mg and 40 mg (3)
CONTRAINDICATIONS
Patien
                                
                                read_full_document
                                
                            

Søk varsler relatert til dette produktet